Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial
… diabetes, and follow-up lipid values, there was still a significant reduction in the prevalence of fatty liver in the treatment group (OR=0.36, 95% CI=0.16–0.83, P=0.017). Follow-up TG …..... Read More